Core Viewpoint - China Shangcheng (02330) announced a placement agreement with a placement agent to issue up to 75.4743 million new shares at a price of HKD 0.180 per share, representing a discount of approximately 7.69% compared to the closing price of HKD 0.195 on October 16, 2025 [1] Group 1 - The placement shares represent about 16.67% of the enlarged issued share capital [1] - The estimated net proceeds from the placement are approximately HKD 13.52 million [1] - The company intends to use the net proceeds for general working capital, including employee costs, professional fees, rent, and general administrative and operational expenses [1]

Core Viewpoint - 惠陶集团 plans to place a maximum of 17.416 million shares, representing 16.66% of the enlarged total share capital, at a price of HKD 0.34 per share, which is approximately a 20% discount to the closing price of HKD 0.425 [1] Summary by Category - **Share Placement Details** - The company intends to issue up to 17.416 million shares [1] - The placement price is set at HKD 0.34 per share, reflecting a discount of about 20% from the last closing price [1] - **Financial Implications** - The placement is expected to raise a maximum of HKD 59.2 million, with net proceeds estimated at approximately HKD 54 million [1] - **Use of Proceeds** - The funds raised will be utilized for the company's current business operations, development, and general working capital [1]

Core Viewpoint - 惠陶集团 plans to issue up to 17,416,000 shares at a price of no less than HKD 0.34 per share, representing approximately 20% of the existing issued shares as of the announcement date [1] Group 1: Share Placement Details - The placement agreement was established with a placement agent, who will facilitate subscriptions from at least six investors during the placement period [1] - The placement price of HKD 0.34 represents a discount of about 20% compared to the closing price of HKD 0.425 on the date of the placement agreement [1] - The maximum gross proceeds from the placement are estimated to be approximately HKD 5.92 million [1] Group 2: Use of Proceeds - The net proceeds from the placement, after deducting the placement agent's commission, professional fees, and other related costs, are expected to be around HKD 5.4 million [1] - The funds will be utilized for current business operations, development, and general working capital expenditures [1]

Core Viewpoint - The announcement from 嘉鼎国际集团 (Jiadeng International Group) indicates the successful completion of a placement of new shares, which will enhance the company's operational funding [1] Group 1 - The board of 嘉鼎国际集团 has confirmed that all conditions for the placement have been met [1] - The placement was completed on October 15, 2025, involving the issuance of 3,851,686 new shares [1] - The net proceeds from the placement amount to approximately HKD 2.9 million, which will be used for general operational funding [1]

Core Viewpoint - Tiancheng Holdings (02110) has announced a placement agreement to issue up to 60 million shares at a price of HKD 0.1 per share, representing approximately 16.67% of the enlarged issued share capital, with a discount of about 13.79% from the closing price on the date of the agreement [1] Summary by Sections - **Placement Details** - The placement is expected to involve at least six independent third-party subscribers [1] - The total gross proceeds from the placement are estimated to be HKD 6 million, with a net amount of approximately HKD 5.71 million after expenses [1] - **Use of Proceeds** - The net proceeds from the placement will be used entirely for general working capital [1]

Group 1 - The company, 康特隆 (01912), has completed a placement agreement, successfully placing a total of 220 million shares [1] - The placement was finalized on October 10, 2025, with shares issued at a price of HKD 0.065 per share, representing approximately 16.67% of the enlarged issued share capital post-placement [1] - The net proceeds from the placement amount to approximately HKD 12.83 million, with plans to use at least HKD 10 million for debt repayment and the remaining for general working capital [1]

Core Viewpoint - InnoCare Pharma (02577) plans to issue 20.7 million new H-shares at a price of HKD 75.58 per share, representing a discount of approximately 7.88% from the closing price on October 9, 2023 [1] Summary by Categories Share Issuance - The proposed share issuance will account for approximately 3.94% of the enlarged H-share capital and about 2.26% of the total issued shares [1] Financial Details - The total expected proceeds from the share placement are approximately HKD 1.5645 billion, with net proceeds estimated at around HKD 1.5504 billion [1] Use of Proceeds - Approximately 31% of the net proceeds will be allocated for capacity expansion and continuous product upgrades - About 24% will be used to repay interest-bearing debts - Approximately 45% will be designated for working capital and general corporate purposes [1]

假设所有配售股份均获悉数配售，预计配售所得款项总额及所得款项净额分别为15.645亿港元及约 15.504亿港元。配售所得款项净额拟用于以下用途：(1)约31%的资金用于产能扩充及产品持续迭代升 级。(2)约24%的资金用于偿还有息负债。(3)约45%的资金用作营运资金及一般公司用途。 英诺赛科(02577)发布公告，于2025年10月10日，公司拟配售2070万股新H股，分别占经配发及发行配售 股份扩大后的H股及已发行股份总数的约3.94%及约2.26%。配售价每股H股75.58港元，较10月9日收市 价每股H股82.05港元折让约7.88%。 ...

Core Viewpoint - The company has entered into a placement and subscription agreement with the subscriber, Mr. Lam Kwok Hing, the chairman, executive director, and CEO, to issue 30.606 million shares at a price of HKD 0.476 per share [1] Group 1: Share Placement Details - The company will place 30.606 million shares to no fewer than six subscribers [1] - Mr. Lam Kwok Hing will subscribe for the same number of shares at the same price of HKD 0.476 per share [1] - The shares represent approximately 17.14% of the existing share capital or about 14.63% of the enlarged share capital [1] Group 2: Financial Implications - The total gross proceeds and net proceeds from the placement are expected to be approximately HKD 14.6 million and HKD 14.2 million, respectively [1] - The net proceeds will be used for renovating the Shanghai logistics center, upgrading furniture and logistics equipment, purchasing new equipment, expanding the workforce at the Dongguan processing center, and general working capital [1]

Core Viewpoint - 基石科技控股 announced a conditional placement agreement to issue up to 127 million shares at a price of HKD 0.57 per share, representing an approximate 18.57% discount to the closing price on the agreement date [1] Group 1: Placement Details - The placement will be made to no fewer than six independent third-party investors [1] - The maximum 127 million shares represent about 11.41% of the enlarged issued share capital post-placement [1] - The estimated total gross proceeds from the placement are approximately HKD 72.39 million, with net proceeds expected to be around HKD 70.06 million after costs [1] Group 2: Use of Proceeds - Approximately 42.91% of the net proceeds will be allocated for general working capital [1] - About 37.11% will be used for project capital expenditures [1] - Approximately 14.27% will cover financing costs, and around 5.71% will be allocated for marketing and investor relations expenses [1]